FAM122A expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 9.743400E-03 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.090100E-02 |
Normal-vs-Stage2 |
1.373600E-01 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.338370E-01 |
Stage1-vs-Stage2 |
9.371800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.761200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
7.079800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.137700E-02 |
Normal-vs-AfricanAmerican |
4.478200E-01 |
Normal-vs-Asian |
3.637800E-02 |
Caucasian-vs-AfricanAmerican |
1.770230E-01 |
Caucasian-vs-Asian |
5.772600E-01 |
AfricanAmerican-vs-Asian |
5.810000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.681500E-02 |
Normal-vs-Female |
4.683900E-02 |
Male-vs-Female |
9.830600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.220000E-01 |
Normal-vs-Extreme_Weight |
1.350360E-01 |
Normal-vs-Obese |
2.081600E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
3.751200E-01 |
Normal_Weight-vs-Obese |
3.603600E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.154400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.821400E-04 |
Normal-vs-Age(41-60Yrs) |
1.320990E-01 |
Normal-vs-Age(61-80Yrs) |
5.443900E-02 |
Normal-vs-Age(81-100Yrs) |
4.294800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.450600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.021000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.175840E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.950800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.427000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.107600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.369800E-01 |
Normal-vs-Grade 3 |
8.262600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
5.296600E-01 |
Grade 2-vs-Grade 4 |
6.369800E-01 |
Grade 3-vs-Grade 4 |
8.262600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.616500E-02 |
Normal-vs-N1 |
1.338930E-03 |
N0-vs-N1 |
2.103800E-01 |
|
|